C07C 49/223
Polycyclic
Official title: polycyclic
C07C49/223 (Polycyclic) appears on 54 US grants and 22 published applications in this corpus.
Search patents in C07C- Granted patents
- 54
- Published applications
- 22
- Assignees
- 44
- Inventors
- 147
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 7 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 3 |
| 2011 | 1 | 0 |
| 2012 | 2 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of the n-terminal domain of the androgen receptor10 Dec 2024US 12,162,818 B2The Regents of the University of California
- Benzylideneacetone derivative and use thereof18 Apr 2023US 11,629,121 B2Gyeonggido Business & Science Accelerator
- Inhibitors of the N-terminal domain of the androgen receptor1 Mar 2022US 11,261,152 B2The Regents of the University of California
- MTOR-independent activator of TFEB for autophagy enhancement and uses thereof10 Jan 2017US 9,540,299 B2Hong Kong Baptist University
- Anti-invasive compounds22 Mar 2016US 9,290,427 B2Universiteit Gent
- Ortho-phthalaldehyde-functionalized ultravioletabsorbers and visible chromophores for semi-permanent topical applications1 Oct 2026US 2026/0297038 A1The Regents of the University of Colorado, a body corporate
- Hydrogenation of dienals or dienones with rhodium complexes under carbon monoxide free atmosphere27 Jun 2024US 2024/0208891 A1
- Composition for treating or preventing inflammatory bowel disease27 Apr 2023US 2023/0125487 A1Fugenbio Co., Ltd.
- Inhibitors of the n-terminal domain of the androgen receptor1 Dec 2022US 2022/0380298 A1The Regents of the University of California
- Inhibitors of the n-terminal domain of the androgen receptor9 Jun 2022US 2022/0177418 A1The Regents of the University of California
Most cited
By later US patents
- Naphthalene derivatives having retinoid type action, the process for preparation thereof and medicinal and cosmetic compositions containing them104US 4,879,284 AL'oreal · 1989
- Fungicidal compounds82US 4,243,405 AImperial Chemical Industries PLC · 1981
- Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures40US 7,345,301 B2Merck Patent GmbH · 2008
- Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states26US 6,462,075 B1Emory University · 2002
- 1-Aryl-1-lower alkyl-1-buten-3-ols and ester derivatives16US 4,081,476 ASandoz Ltd. · 1978